Performance of COVID-19 case-based surveillance system in FCT, Nigeria, March 2020-January 2021

被引:4
|
作者
Umeozuru, Chikodi Modesta [1 ,2 ]
Usman, Aishat Bukola [2 ]
Olorukooba, Abdulhakeem Abayomi [3 ]
Abdullahi, Idris Nasir [4 ]
John, Doris Japhet [5 ]
Lawal, Lukman Ademola [5 ]
Uwazie, Charles Chukwudi [1 ,2 ]
Balogun, Muhammad Shakir [2 ]
机构
[1] Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria
[2] African Field Epidemiol Network AFENET, Abuja, Nigeria
[3] Ahmadu Bello Univ, Dept Community Med, Zaria, Kaduna, Nigeria
[4] Ahmadu Bello Univ, Dept Med Lab Sci, Zaria, Kaduna State, Nigeria
[5] Fed Capital Terr Adm, Dept Publ Hlth, Abuja, Nigeria
来源
PLOS ONE | 2022年 / 17卷 / 04期
关键词
D O I
10.1371/journal.pone.0264839
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction The emergence of novel SARS-CoV-2 has caused a pandemic of Coronavirus Disease 19 (COVID-19) which has spread exponentially worldwide. A robust surveillance system is essential for correct estimation of the disease burden and containment of the pandemic. We evaluated the performance of COVID-19 case-based surveillance system in FCT, Nigeria and assessed its key attributes. Methods We used a cross-sectional study design, comprising a survey, key informant interview, record review and secondary data analysis. A self-administered, semi-structured questionnaire was administered to key stakeholders to assess the attributes and process of operation of the surveillance system using CDC's Updated Guidelines for Evaluation of Public Health Surveillance System 2001. Data collected alongside surveillance data from March 2020 to January 2021 were analyzed and summarized using descriptive statistics. Results Out of 69,338 suspected cases, 12,595 tested positive with RT-PCR with a positive predictive value (PPV) of 18%. Healthcare workers were identified as high-risk group with a prevalence of 23.5%. About 82% respondents perceived the system to be simple, 85.5% posited that the system was flexible and easily accommodates changes, 71.4% reported that the system was acceptable and expressed willingness to continue participation. Representativeness of the system was 93%, stability 40%, data quality 56.2% and timeliness 45.5%, estimated result turnaround time (TAT) was suboptimal. Conclusion The system was found to be useful, simple, flexible, sensitive, acceptable, with good representativeness but the stability, data quality and timeliness was poor. The system meets initial surveillance objectives but rapid expansion of sample collection and testing sites, improvement of TAT, sustainable funding, improvement of electronic database, continuous provision of logistics, supplies and additional trainings are needed to address identified weaknesses, optimize the system performance and meet increasing need of case detection in the wake of rapidly spreading pandemic. More risk-group persons should be tested to improve surveillance effectiveness.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Temporal study of wastewater surveillance from September 2020 to March 2021: an estimation of COVID-19 patients in Lahore, Pakistan
    Ashraf, Muhammad Adnan
    Nawaz, Muhammad
    Asif, Ali
    Ali, Muhammad Asad
    Mehmood, Adnan
    Aziz, Muhammad Waqar
    Shabbir, Muhammad Zubair
    Mukhtar, Nadia
    Shabbir, Muhammad Abu Bakr
    Raza, Sohail
    Yaqub, Tahir
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2023, 30 (33) : 80855 - 80862
  • [32] Epidemiology of COVID-19 and effect of public health interventions, Chennai, India, March-October 2020: an analysis of COVID-19 surveillance system
    Jagadeesan, M.
    Ganeshkumar, Parasuraman
    Kaur, Prabhdeep
    Sriramulu, Hemalatha Masanam
    Sakthivel, Manikandanesan
    Rubeshkumar, Polani
    Raju, Mohankumar
    Murugesan, Lakshmidevi
    Ganapathi, Raajkumar
    Srinivasan, Mahalakshmi
    Sukumar, Aswini
    Ilangovan, Kumaravel
    Reddy, Madhusudhan
    Shanmugam, Divyadharshini
    Govindasamy, Prakash
    Murhekar, Manoj
    BMJ OPEN, 2022, 12 (03):
  • [33] Racial Disparities in Newly Diagnosed Hematological Malignancies in the United States during the COVID-19 Pandemic, January 2020 to March 2021
    Bhandari, Sudip
    Chawla, Jitesh
    Jain, Prerna
    Kaushiva, Alpana
    Lagor, Charles
    Lal, Lincy S.
    Mueller, Judith
    Whyte, Warren
    BLOOD, 2022, 140 : 13269 - 13270
  • [34] Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021
    Shimabukuro, Tom
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (04): : 125 - 129
  • [35] Nigeria's public health response to the COVID-19 pandemic: January to May 2020
    Dan-Nwafor, Chioma
    Ochu, Chinwe Lucia
    Elimian, Kelly
    Oladejo, John
    Ilori, Elsie
    Umeokonkwo, Chukwuma
    Steinhardt, Laura
    Igumbor, Ehimario
    Wagai, John
    Okwor, Tochi
    Aderinola, Olaolu
    Mba, Nwando
    Hassan, Assad
    Dalhat, Mahmood
    Jinadu, Kola
    Badaru, Sikiru
    Arinze, Chinedu
    Jafiya, Abubakar
    Disu, Yahya
    Saleh, Fatima
    Abubakar, Anwar
    Obiekea, Celestina
    Yinka-Ogunleye, Adesola
    Naidoo, Dhamari
    Namara, Geoffrey
    Muhammad, Saleh
    Ipadeola, Oladipupo
    Ofoegbunam, Chinenye
    Ogunbode, Oladipo
    Akatobi, Charles
    Alagi, Matthias
    Yashe, Rimamdeyati
    Crawford, Emily
    Okunromade, Oyeladun
    Aniaku, Everistus
    Mba, Sandra
    Agogo, Emmanuel
    Olugbile, Michael
    Eneh, Chibuzo
    Ahumibe, Anthony
    Nwachukwu, William
    Ibekwe, Priscilla
    Adejoro, Ope-Oluwa
    Ukponu, Winifred
    Olayinka, Adebola
    Okudo, Ifeanyi
    Aruna, Olusola
    Yusuf, Fatima
    Alex-Okoh, Morenike
    Fawole, Temidayo
    JOURNAL OF GLOBAL HEALTH, 2020, 10 (02)
  • [36] A CASE SERIES OF RHEUMATIC DISEASE PATIENTS DIAGNOSED WITH COVID-19 FEB 2020 TO MARCH 2021 AT THE HOSPITAL THAT REPORTED LONDON'S INDEX CASE OF COVID-19
    Pilcher, James
    Yanni, Ghada
    Lutalo, Pamela
    Pollard, Louise
    RHEUMATOLOGY, 2022, 61 : I55 - I55
  • [37] Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021
    Painter, Elizabeth M.
    Ussery, Emily N.
    Patel, Anita
    Hughes, Michelle M.
    Zell, Elizabeth R.
    Moulia, Danielle L.
    Scharf, Lynn Gibbs
    Lynch, Michael
    Ritchey, Matthew D.
    Toblin, Robin L.
    Murthy, Bhavini Patel
    Harris, LaTreace Q.
    Wasley, Annemarie
    Rose, Dale A.
    Cohn, Amanda
    Messonnier, Nancy E.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (05): : 174 - 177
  • [38] Ecological Analysis of the Decline in Incidence Rates of COVID-19 Among Nursing Home Residents Associated with Vaccination, United States, December 2020-January 2021
    Benin, Andrea L.
    Soe, Minn M.
    Edwards, Jonathan R.
    Bagchi, Suparna
    Link-Gelles, Ruth
    Schrag, Stephanie J.
    Herzer, Kurt
    Verani, Jennifer R.
    Budnitz, Daniel
    Nanduri, Srinivas
    Jernigan, John
    Edens, Chris
    Gharpure, Radhika
    Patel, Anita
    Wu, Hsiu
    Golshir, Beth C.
    Jaffe, Aaron
    Li, Qunna
    Srinivasan, Arjun
    Shulman, Evan
    Ling, Shari M.
    Moody-Williams, Jean
    Fleisher, Lee A.
    Pollock, Daniel A.
    Bell, Jeneita
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (10) : 2009 - 2015
  • [39] Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022
    Kompaniyets, Lyudmyla
    Bull-Otterson, Lara
    Boehmer, Tegan K.
    Baca, Sarah
    Alvarez, Pablo
    Hong, Kai
    Hsu, Joy
    Harris, Aaron M.
    Gundlapalli, Adi, V
    Saydah, Sharon
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (31): : 993 - 999
  • [40] Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022
    Kompaniyets, Lyudmyla
    Bull-Otterson, Lara
    Boehmer, Tegan K.
    Baca, Sarah
    Alvarez, Pablo
    Hong, Kai
    Hsu, Joy
    Harris, Aaron M.
    Gundlapalli, Adi, V
    Saydah, Sharon
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 71 (31): : 993 - 999